trending Market Intelligence /marketintelligence/en/news-insights/trending/a15LekC9CPqK0Flo6aK6zQ2 content esgSubNav
In This List

DBV Technologies chief medical officer resigns; interim named

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


DBV Technologies chief medical officer resigns; interim named

DBV Technologies S.A. said Lucia Septien-Velez is leaving her role as the company's chief medical officer to pursue other opportunities.

Hugh Sampson, DBV's chief scientific officer since June 2015, will now also serve as interim chief medical officer.

Paris-based DBV Technologies is developing a proprietary technology platform for use in immunotherapy.